482506854	482506854	CD	B-NP	O
|	|	NN	I-NP	O
ERH	ERH	NN	I-NP	O
|	|	NN	I-NP	O
18073415	18073415	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
775999	775999	CD	B-NP	O
|	|	CC	I-NP	O
1/27/2002	1/27/2002	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Stent	Stent	NNP	I-NP	O
stenoses	stenosis	NNS	I-NP	O
,	,	,	O	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
asymptomatic	asymptomatic	JJ	B-NP	O
afib	afib	NN	I-NP	O
,	,	,	O	O
aflutter	aflutter	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
atrial	atrial	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
with	with	IN	B-PP	O
RVR	RVR	NN	B-NP	B-protein
|	|	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/8/2002	2/8/2002	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/12/2002	10/12/2002	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
RORK	RORK	NN	B-NP	B-protein
,	,	,	O	O
HUBERT	HUBERT	NN	B-NP	O
379-90-70-7	379-90-70-7	CD	I-NP	O
Sta	Sta	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
CAR	CAR	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
PATIENT	PATIENT	NN	I-NP	O
ON	ON	NN	I-NP	O
:	:	:	O	O
9/14/02	9/14/02	CD	B-NP	O
AT	AT	NN	I-NP	O
05	05	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
HO	HO	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
MESIONA	MESIONA	NNP	B-NP	O
,	,	,	O	O
JEREMY	JEREMY	NNP	B-NP	O
VITO	VITO	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ECASA	ECASA	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ASPIRIN	ASPIRIN	NNP	I-NP	O
ENTERIC	ENTERIC	NNP	I-NP	O
COATED	COATED	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
325	325	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
4/3/02	4/3/02	CD	B-NP	O
by	by	IN	B-PP	O
BELLEVILLE	BELLEVILLE	NNP	B-NP	O
,	,	,	O	O
BURT	BURT	NNP	B-NP	O
B.	B.	NNP	I-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
39106875	39106875	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Will	Will	MD	B-VP	O
monitor	monitor	NN	B-NP	O
PT	PT	NN	I-NP	O
.	.	.	O	O

MIACALCIN	MIACALCIN	NN	B-NP	B-protein
-LRB-	-LRB-	HYPH	I-NP	O
CALCITONIN-SALMON	CALCITONIN-SALMON	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	O
1	1	CD	I-NP	O
SPRAY	SPRAY	NN	I-NP	O
NA	NA	NN	I-NP	O
QOD	QOD	NN	I-NP	O
Number	Number	NN	I-NP	O
of	of	IN	B-PP	O
Doses	Dose	NNS	B-NP	O
Required	Require	VBN	B-VP	O
-LRB-	-LRB-	HYPH	B-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
10	10	CD	B-NP	O
CALCIUM	CALCIUM	NN	I-NP	O
CARBONATE	CARBONATE	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
500	500	CD	I-NP	O
MG	MG	NN	I-NP	O
ELEM	ELEM	NN	I-NP	O
.	.	.	O	O

CA	CA	NN	B-NP	O
+	+	SYM	O	O
+	+	SYM	B-NP	O
-RRB-	-RRB-	SYM	B-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
250	250	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
GUAIFENESIN	GUAIFENESIN	NN	I-NP	O
10	10	CD	B-NP	O
MILLILITERS	MILLILITERS	NNS	I-NP	O
PO	PO	NN	I-NP	O
Q4H	Q4H	NN	I-NP	O
PRN	PRN	NN	I-NP	O
cough	cough	NN	I-NP	O
LOPRESSOR	LOPRESSOR	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
METOPROLOL	METOPROLOL	NN	I-NP	O
TARTRATE	TARTRATE	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
75	75	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
TID	TID	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
HR	HR	NN	B-NP	B-protein
<	<	SYM	B-ADJP	I-protein
50	50	CD	B-NP	I-protein
,	,	,	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
95	95	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/14/02	9/14/02	CD	B-NP	O
by	by	IN	B-PP	O
MESKO	MESKO	NNP	B-NP	O
,	,	,	O	O
ELDEN	ELDEN	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
VERAPAMIL	VERAPAMIL	NN	B-NP	B-protein
HCL	HCL	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
60	60	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
TID	TID	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
57503813	57503813	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
METOPROLOL	METOPROLOL	NNP	B-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
&	&	CC	I-NP	O
VERAPAMIL	VERAPAMIL	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/24/02	10/24/02	CD	B-NP	O
by	by	IN	B-PP	O
SCHAF	SCHAF	NNP	B-NP	B-protein
,	,	,	O	O
JORDON	JORDON	NNP	B-NP	O
OLIVER	OLIVER	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
VERAPAMIL	VERAPAMIL	NN	B-NP	B-protein
HCL	HCL	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
80	80	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
TID	TID	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
90825504	90825504	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
METOPROLOL	METOPROLOL	NNP	B-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
&	&	CC	I-NP	O
VERAPAMIL	VERAPAMIL	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/24/02	10/24/02	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
VERAPAMIL	VERAPAMIL	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
Override	Override	NN	I-NP	O
Notice	Notice	NNP	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/24/02	10/24/02	CD	B-NP	O
by	by	IN	B-PP	O
RASNAKE	RASNAKE	NN	B-NP	O
,	,	,	O	O
JEFFEREY	JEFFEREY	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
VERAPAMIL	VERAPAMIL	NN	B-NP	B-protein
HCL	HCL	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
60764249	60764249	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
METOPROLOL	METOPROLOL	NNP	B-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
&	&	CC	I-NP	O
VERAPAMIL	VERAPAMIL	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
THEOPHYLLINE	THEOPHYLLINE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SLOW	SLOW	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
300	300	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Follow	Follow	NNP	I-NP	O
manufacturer	manufacturer	NN	I-NP	O
's	's	POS	B-NP	O
info	info	NN	I-NP	O
re	re	NN	I-NP	O
:	:	:	O	O
take	take	VB	B-VP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	O
.	.	.	O	O

Give	Give	VB	B-VP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
4/3/02	4/3/02	CD	B-NP	O
by	by	IN	B-PP	O
DANNER	DANNER	NNP	B-NP	O
,	,	,	O	O
VINCE	VINCE	NNP	B-NP	O
F.	F.	NNP	I-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
39106875	39106875	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
THEOPHYLLINE	THEOPHYLLINE	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Will	Will	MD	B-VP	O
monitor	monitor	NN	B-NP	O
PT	PT	NN	I-NP	O
.	.	.	O	O

VERAPAMIL	VERAPAMIL	NN	B-NP	B-protein
HCL	HCL	NN	I-NP	I-protein
60	60	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
TID	TID	NN	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
sbp	sbp	NN	B-NP	O
<	<	SYM	O	O
95	95	CD	B-NP	O
,	,	,	O	O
hr	hr	NN	B-NP	O
<	<	SYM	O	O
55	55	CD	B-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/14/02	9/14/02	CD	B-NP	O
by	by	IN	B-PP	O
RECHICHI	RECHICHI	NNP	B-NP	O
,	,	,	O	O
GERRY	GERRY	NNP	B-NP	O
C.	C.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
METOPROLOL	METOPROLOL	NNP	B-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
&	&	CC	I-NP	O
VERAPAMIL	VERAPAMIL	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/24/02	10/24/02	CD	B-NP	O
by	by	IN	B-PP	O
YESTRAMSKI	YESTRAMSKI	NNP	B-NP	O
,	,	,	O	O
ABE	ABE	NNP	B-NP	O
D.	D.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
METOPROLOL	METOPROLOL	NNP	B-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
&	&	CC	I-NP	O
VERAPAMIL	VERAPAMIL	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
METOPROLOL	METOPROLOL	NNP	B-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
&	&	CC	I-NP	O
VERAPAMIL	VERAPAMIL	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/24/02	10/24/02	CD	B-NP	O
by	by	IN	B-PP	O
TURLA	TURLA	NN	B-NP	B-protein
,	,	,	O	O
THERON	THERON	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
METOPROLOL	METOPROLOL	NNP	B-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
&	&	CC	I-NP	O
VERAPAMIL	VERAPAMIL	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
METOPROLOL	METOPROLOL	NNP	B-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
&	&	CC	I-NP	O
VERAPAMIL	VERAPAMIL	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Aware	Aware	NNP	B-NP	O
Previous	Previous	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
Override	Override	NNP	I-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
10/24/02	10/24/02	CD	B-NP	O
by	by	IN	B-PP	O
KOLEN	KOLEN	NNP	B-NP	O
,	,	,	O	O
MANUAL	MANUAL	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
LOPRESSOR	LOPRESSOR	NN	B-NP	B-protein
PO	PO	NN	I-NP	I-protein
75	75	CD	I-NP	I-protein
MG	MG	NN	I-NP	I-protein
TID	TID	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
ref	ref	NN	I-NP	I-protein
#	#	#	B-NP	I-protein
60523561	60523561	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	I-protein
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
VERAPAMIL	VERAPAMIL	NNP	B-NP	O
HCL	HCL	NNP	I-NP	O
&	&	CC	I-NP	O
METOPROLOL	METOPROLOL	NNP	I-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
Previous	Previous	JJ	I-NP	O
override	override	NN	I-NP	O
information	information	NN	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/24/02	10/24/02	CD	B-NP	O
by	by	IN	B-PP	O
FISCHETTI	FISCHETTI	NNP	B-NP	O
,	,	,	O	O
DEXTER	DEXTER	NNP	B-NP	O
M.	M.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
METOPROLOL	METOPROLOL	NNP	B-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
&	&	CC	I-NP	O
VERAPAMIL	VERAPAMIL	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
METOPROLOL	METOPROLOL	NNP	B-NP	O
TARTRATE	TARTRATE	NNP	I-NP	O
&	&	CC	I-NP	O
VERAPAMIL	VERAPAMIL	NNP	I-NP	O
HCL	HCL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
aware	aware	JJ	B-NP	O
COUMADIN	COUMADIN	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
5	5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
No	No	NNP	I-NP	O
high	high	JJ	I-NP	O
Vitamin-K	Vitamin-K	NN	I-NP	O
containing	contain	VBG	B-VP	O
foods	food	NNS	B-NP	O
Alert	Alert	NNP	B-NP	O
overridden	overridden	JJ	B-ADJP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
4/3/02	4/3/02	CD	B-NP	O
by	by	IN	B-PP	O
TRIPPI	TRIPPI	NNP	B-NP	O
,	,	,	O	O
ANTHONY	ANTHONY	NNP	B-NP	O
D.	D.	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
ASPIRIN	ASPIRIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
THEOPHYLLINE	THEOPHYLLINE	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Will	Will	MD	B-VP	O
monitor	monitor	NN	B-NP	O
PT	PT	NN	I-NP	O
.	.	.	O	O

SIMVASTATIN	SIMVASTATIN	NN	B-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QHS	QHS	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Override	Override	NNP	B-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
4/3/02	4/3/02	CD	B-NP	O
by	by	IN	B-PP	O
MATTES	MATTES	NNP	B-NP	O
,	,	,	O	O
QUINTON	QUINTON	NNP	B-NP	O
A.	A.	NN	I-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
COUMADIN	COUMADIN	NN	B-NP	O
PO	PO	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
39106875	39106875	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
WARFARIN	WARFARIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
Will	Will	MD	B-VP	O
monitor	monitor	NN	B-NP	O
PT	PT	NN	I-NP	O
.	.	.	O	O

SEREVENT	SEREVENT	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SALMETEROL	SALMETEROL	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NN	I-NP	O
INH	INH	NN	I-NP	O
BID	BID	NN	I-NP	O
FLOVENT	FLOVENT	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FLUTICASONE	FLUTICASONE	NN	I-NP	O
PROPIONATE	PROPIONATE	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
220	220	CD	I-NP	O
MCG	MCG	NNP	I-NP	O
INH	INH	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
two	two	CD	B-NP	O
puffs	puff	NNS	I-NP	O
CLOPIDOGREL	CLOPIDOGREL	NN	I-NP	O
75	75	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
IN	IN	NNP	I-NP	O
AM	AM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
1/11	1/11	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
ALBUTEROL	ALBUTEROL	NN	I-NP	B-protein
INHALER	INHALER	NN	I-NP	I-protein
2	2	CD	I-NP	I-protein
PUFF	PUFF	NN	I-NP	I-protein
INH	INH	NN	I-NP	O
PRN	PRN	NN	I-NP	O
shortness	shortness	NN	I-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
RETURN	RETURN	NNP	I-NP	O
TO	TO	NNP	I-NP	O
WORK	WORK	NNP	I-NP	O
:	:	:	O	O
Not	Not	NNP	B-NP	O
Applicable	Applicable	NNP	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Vance	Vance	NNP	I-NP	O
Klopfenstein	Klopfenstein	NNP	I-NP	O
,	,	,	O	O
Termclint	Termclint	NNP	B-NP	O
University	University	NNP	I-NP	O
Of	Of	IN	B-PP	O
And	And	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
,	,	,	O	O
1pm	1pm	NN	B-NP	O
5/17/02	5/17/02	CD	I-NP	O
scheduled	schedule	VBN	B-VP	O
,	,	,	O	O
Dewitt	Dewitt	NNP	B-NP	O
Search	Search	NNP	I-NP	O
8/12/02	8/12/02	CD	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NNP	B-NP	O
:	:	:	O	O
Penicillins	Penicillins	NNP	B-NP	O
,	,	,	O	O
Sulfa	Sulfa	NNP	B-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Stent	Stent	NNP	I-NP	O
stenoses	stenose	VBZ	B-VP	O
,	,	,	O	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
asymptomatic	asymptomatic	JJ	B-NP	O
afib	afib	NN	I-NP	O
,	,	,	O	O
aflutter	aflutter	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
atrial	atrial	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
with	with	IN	B-PP	O
RVR	RVR	NN	B-NP	B-protein
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
cad	cad	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
coronary	coronary	JJ	I-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
copd	copd	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
chronic	chronic	JJ	I-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
niddm	niddm	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
diabetes	diabetes	NN	I-NP	O
mellitus	mellitus	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
afib	afib	NN	B-NP	O
,	,	,	O	O
aflutter	aflutter	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
atrial	atrial	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
Cardiac	Cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
with	with	IN	B-PP	O
angioplasty	angioplasty	NN	B-NP	O
of	of	IN	B-PP	O
OM	OM	NN	B-NP	O
and	and	CC	O	O
Diagonal	Diagonal	JJ	B-NP	O
arteries	artery	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
brachytherapy	brachytherapy	NN	B-NP	O
.	.	.	O	O

OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
None	None	NNP	I-NP	O
BRIEF	BRIEF	NNP	I-NP	O
RESUME	RESUME	NNP	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	NNP	B-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
75yo	75yo	CD	B-NP	O
male	male	JJ	I-NP	O
with	with	IN	B-PP	O
COPD	COPD	NN	B-NP	O
,	,	,	O	O
NIDDM	NIDDM	NN	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
CAD	CAD	NN	B-NP	O
s/p	s/p	NN	I-NP	O
cath	cath	NN	I-NP	O
in	in	IN	B-PP	O
3/10	3/10	CD	B-NP	O
with	with	IN	B-PP	O
stents	stent	NNS	B-NP	O
of	of	IN	B-PP	O
LCX	LCX	NN	B-NP	B-protein
and	and	CC	I-NP	O
diag	diag	NN	I-NP	O
,	,	,	O	O
presented	present	VBN	B-VP	O
to	to	TO	B-PP	O
MSH	MSH	NN	B-NP	B-protein
on	on	IN	B-PP	O
11/9/02	11/9/02	NN	B-NP	O
with	with	IN	B-PP	O
CP	CP	NN	B-NP	B-DNA
,	,	,	O	O
similar	similar	JJ	B-ADJP	O
to	to	TO	B-PP	O
that	that	DT	B-NP	O
in	in	IN	B-PP	O
9/11	9/11	CD	B-NP	O
Pt	Pt	NN	I-NP	O
described	describe	VBD	B-VP	O
CP	CP	NN	B-NP	B-DNA
as	as	IN	B-PP	O
pain	pain	NN	B-NP	O
and	and	CC	I-NP	O
pressure	pressure	NN	I-NP	O
,	,	,	O	O
extending	extend	VBG	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
middle	middle	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
chest	chest	NN	I-NP	O
up	up	RP	B-PRT	O
into	into	IN	B-PP	O
his	his	PRP$	B-NP	O
jaw	jaw	NN	I-NP	O
.	.	.	O	O

Pain	Pain	NNP	B-NP	O
began	begin	VBD	B-VP	O
when	when	WRB	B-ADVP	O
pt	pt	NN	B-NP	O
arose	arise	VBD	B-VP	O
from	from	IN	B-PP	O
his	his	PRP$	B-NP	O
couch	couch	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
escalated	escalate	VBN	B-VP	O
quickly	quickly	RB	B-ADVP	O
.	.	.	O	O

CP	CP	NN	B-NP	B-DNA
only	only	RB	B-ADVP	O
ceased	cease	VBD	B-VP	O
after	after	IN	B-SBAR	O
nitro	nitro	NN	B-NP	O
was	be	VBD	B-VP	O
administered	administer	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ER	ER	NN	I-NP	O
30	30	CD	B-NP	O
minutes	minute	NNS	I-NP	O
later	later	RB	B-ADVP	O
.	.	.	O	O

At	At	IN	B-PP	O
LC	LC	NN	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
by	by	IN	B-PP	O
enzymes	enzyme	NNS	B-NP	B-protein
,	,	,	O	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
EKG	EKG	NN	I-NP	O
ischemic	ischemic	JJ	I-NP	O
changes	change	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
Lovenox	Lovenox	NN	B-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
GMH	GMH	NN	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
asymptomatic	asymptomatic	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
,	,	,	O	O
resolving	resolve	VBG	B-VP	O
spontaneously	spontaneously	RB	B-ADVP	O
.	.	.	O	O

On	On	IN	B-PP	O
8/11/02	8/11/02	CD	B-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
MHC	MHC	NN	B-NP	B-protein
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
cath	cath	NN	I-NP	O
and	and	CC	O	O
potential	potential	JJ	B-NP	O
stent/brachytherapy	stent/brachytherapy	NN	I-NP	O
if	if	IN	B-SBAR	O
necessary	necessary	JJ	B-ADJP	O
.	.	.	O	O

Hospital	Hospital	NN	B-NP	O
course	course	NN	I-NP	O
:	:	:	O	O
CV	CV	NN	B-NP	O
-	-	HYPH	O	O
Pt	Pt	NN	B-NP	O
underwent	undergo	VBD	B-VP	O
cath	cath	NN	B-NP	B-protein
3/24/02	3/24/02	CD	I-NP	I-protein
.	.	.	O	O

Both	Both	DT	B-NP	O
stents	stent	NNS	I-NP	O
from	from	IN	B-PP	O
3/10	3/10	CD	B-NP	O
were	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
stenosed	stenose	VBN	I-VP	O
-LRB-	-LRB-	NN	B-NP	O
LACX	LACX	NN	I-NP	O
85	85	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	I-NP	O
diagonal	diagonal	JJ	I-NP	O
95	95	CD	I-NP	O
%	%	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

LAD	LAD	NN	B-NP	O
had	have	VBD	B-VP	O
50	50	CD	B-NP	O
%	%	NN	I-NP	O
stenosis	stenosis	NN	I-NP	O
.	.	.	O	O

Stents	Stent	NNS	B-NP	O
were	be	VBD	B-VP	O
tx	tx	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
angioplasty	angioplasty	NN	I-NP	O
and	and	CC	I-NP	O
brachytherapy	brachytherapy	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
placed	place	VBN	B-VP	O
on	on	IN	B-PP	O
integrilin	integrilin	NN	B-NP	O
IV	IV	CD	I-NP	O
for	for	IN	B-PP	O
14	14	CD	B-NP	O
hours	hour	NNS	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
per	per	IN	B-PP	O
routine	routine	NN	B-NP	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
by	by	IN	B-PP	O
CK	CK	NN	B-NP	B-protein
after	after	IN	B-PP	O
procedure	procedure	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
no	no	DT	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
after	after	IN	B-PP	O
his	his	PRP$	B-NP	O
admission	admission	NN	I-NP	O
to	to	TO	B-PP	O
GUH	GUH	NN	B-NP	B-protein
.	.	.	O	O

-	-	HYPH	B-NP	O
Pt	Pt	NN	I-NP	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
multiple	multiple	JJ	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
asymptomatic	asymptomatic	JJ	B-NP	O
afib	afib	NN	I-NP	O
,	,	,	O	O
aflutter	aflutter	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
atrial	atrial	JJ	B-NP	O
tachycardia	tachycardia	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
RVR	RVR	NN	B-NP	B-protein
into	into	IN	B-PP	O
the	the	DT	B-NP	O
150	150	CD	I-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
rate	rate	NN	B-NP	O
responding	respond	VBG	B-VP	O
well	well	RB	B-ADVP	O
to	to	TO	B-PP	O
5mg	5mg	NN	B-NP	B-protein
IV	IV	CD	I-NP	I-protein
lopressor	lopressor	NN	I-NP	I-protein
.	.	.	O	O

On	On	IN	B-PP	O
4/29/02	4/29/02	CD	B-NP	O
,	,	,	O	O
lopressor	lopressor	NN	B-NP	O
increased	increase	VBD	B-VP	O
to	to	TO	I-VP	O
75mg	75mg	VB	I-VP	O
po	po	NN	B-NP	O
tid	tid	NN	I-NP	O
in	in	IN	B-PP	O
hopes	hope	NNS	B-NP	O
of	of	IN	B-PP	O
achieving	achieve	VBG	B-VP	O
rhythm/rate	rhythm/rate	NN	B-NP	O
control	control	NN	I-NP	O
,	,	,	O	O
unsucessfully	unsucessfully	RB	B-ADVP	O
.	.	.	O	O

EP	EP	NN	B-NP	B-protein
was	be	VBD	B-VP	O
consulted	consult	VBN	I-VP	O
as	as	IN	B-PP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
ablation	ablation	NN	I-NP	O
procedure	procedure	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
felt	feel	VBD	B-VP	O
that	that	IN	B-SBAR	O
medical	medical	JJ	B-NP	O
management	management	NN	I-NP	O
,	,	,	O	O
if	if	IN	B-SBAR	O
possible	possible	JJ	B-ADJP	O
,	,	,	O	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
better	good	JJR	I-NP	O
solution	solution	NN	I-NP	O
,	,	,	O	O
given	give	VBN	B-PP	O
that	that	IN	B-SBAR	O
multifocal	multifocal	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
tachycardias	tachycardia	NNS	I-NP	O
and	and	CC	I-NP	O
afib	afib	NN	I-NP	O
would	would	MD	B-VP	O
not	not	RB	O	O
necessary	necessary	JJ	B-ADJP	O
be	be	VB	B-VP	O
resolved	resolve	VBN	I-VP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ablation	ablation	NN	I-NP	O
procedure	procedure	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
also	also	RB	B-ADVP	O
preferred	prefer	VBD	B-VP	O
medical	medical	JJ	B-NP	O
management	management	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
1/27/02	1/27/02	CD	B-NP	O
,	,	,	O	O
verapamil	verapamil	NN	B-NP	O
40mg	40mg	NN	I-NP	O
po	po	NN	I-NP	O
tid	tid	NN	I-NP	O
was	be	VBD	B-VP	O
added	add	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
regimen	regimen	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
patient	patient	NN	B-NP	O
still	still	RB	B-ADVP	O
having	have	VBG	B-VP	O
episodes	episode	NNS	B-NP	O
of	of	IN	B-PP	O
rapid	rapid	JJ	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
.	.	.	O	O

Verapamil	Verapamil	NN	B-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
80mg	80mg	CD	B-NP	O
po	po	NN	I-NP	O
tid	tid	NN	I-NP	O
with	with	IN	B-PP	O
resulting	result	VBG	B-VP	O
rate	rate	NN	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
had	have	VBD	B-VP	O
two	two	CD	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
asymptomatic	asymptomatic	JJ	B-NP	O
low	low	JJ	I-NP	O
BP	BP	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
90/50	90/50	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
4/6/02	4/6/02	CD	B-NP	O
,	,	,	O	O
verapamil	verapamil	NN	B-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
to	to	TO	I-VP	O
60mg	60mg	VB	I-VP	O
po	po	NN	B-NP	O
tid	tid	NN	I-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
both	both	CC	O	O
HR	HR	NN	B-NP	B-protein
and	and	CC	O	O
BP	BP	NN	B-NP	O
control	control	NN	I-NP	O
.	.	.	O	O

Abnormal	Abnormal	JJ	B-NP	O
rhythms	rhythm	NNS	I-NP	O
continued	continue	VBD	B-VP	O
,	,	,	O	O
without	without	IN	B-PP	O
RVR	RVR	NN	B-NP	B-protein
.	.	.	O	O

-	-	HYPH	B-NP	O
Given	Give	VBN	I-NP	O
afib/aflutter	afib/aflutter	JJ	I-NP	O
rhythms	rhythm	NNS	I-NP	O
,	,	,	O	O
patient	patient	NN	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
5mg	5mg	NN	I-NP	O
po	po	NN	I-NP	O
qd	qd	NN	I-NP	O
on	on	IN	B-PP	O
1/27/02	1/27/02	CD	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-PP	O
his	his	PRP$	B-NP	O
procedure	procedure	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
heparin	heparin	NN	B-NP	O
drip	drip	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
immediately	immediately	RB	B-ADJP	O
post-procedure	post-procedure	JJ	I-ADJP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
integrilin	integrilin	NN	B-NP	B-protein
drip	drip	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

-	-	HYPH	B-NP	O
Pt	Pt	NN	I-NP	O
placed	place	VBN	B-VP	O
on	on	IN	B-PP	O
statin	statin	NN	B-NP	O
at	at	IN	B-PP	O
ACH	ACH	NN	B-NP	O
;	;	:	O	O
maintained	maintain	VBN	B-VP	O
on	on	IN	B-PP	O
statin	statin	NN	B-NP	O
at	at	IN	B-PP	O
AMC	AMC	NN	B-NP	B-protein
.	.	.	O	O

Patient	Patient	NN	B-NP	O
maintained	maintain	VBD	B-VP	O
on	on	IN	B-PP	O
asa	asa	NN	B-NP	O
.	.	.	O	O

-	-	HYPH	B-NP	O
New	New	JJ	I-NP	O
d/c	d/c	NN	I-NP	O
medications	medication	NNS	I-NP	O
:	:	:	O	O
Given	Give	VBN	B-NP	O
difficulty	difficulty	NN	I-NP	O
of	of	IN	B-PP	O
maintaining	maintain	VBG	B-VP	O
patient	patient	NN	B-NP	O
's	's	POS	B-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
,	,	,	O	O
pt	pt	NN	B-NP	O
was	be	VBD	B-VP	O
d/c	d/c	NN	B-NP	O
`	`	``	O	O
ed	ed	VBN	B-VP	O
on	on	IN	B-PP	O
verapamil	verapamil	NN	B-NP	O
and	and	CC	I-NP	O
lopressor	lopressor	NN	I-NP	O
,	,	,	O	O
both	both	DT	B-NP	O
tid	tid	JJ	I-NP	O
drugs	drug	NNS	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
f/u	f/u	NN	B-NP	O
appt	appt	NN	I-NP	O
with	with	IN	B-PP	O
cardiologist	cardiologist	NN	B-NP	O
or	or	CC	I-NP	O
PCP	PCP	NN	I-NP	B-protein
,	,	,	O	O
this	this	DT	B-NP	O
regimen	regimen	NN	I-NP	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
altered	alter	VBN	I-VP	O
as	as	IN	B-PP	O
appropriate	appropriate	JJ	B-ADJP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
also	also	RB	B-ADVP	O
d/c	d/c	NN	B-NP	O
'd	'd	MD	B-VP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
,	,	,	O	O
plavix	plavix	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
for	for	IN	B-PP	O
6months	6month	NNS	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
simvastatin	simvastatin	NN	B-NP	O
.	.	.	O	O

Pulm	Pulm	NN	B-NP	O
-	-	HYPH	I-NP	O
Severe	Severe	JJ	I-NP	O
COPD	COPD	NN	I-NP	O
,	,	,	O	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
home	home	NN	B-NP	O
O2	O2	NN	I-NP	O
.	.	.	O	O

Baseline	Baseline	NNP	B-NP	O
O2	O2	NNP	I-NP	O
92	92	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
2L	2L	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
SOB	SOB	NN	B-NP	B-protein
with	with	IN	B-PP	O
minor	minor	JJ	B-NP	O
exertion	exertion	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
was	be	VBD	B-VP	O
tx	tx	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
steroids	steroid	NNS	I-NP	O
until	until	IN	B-PP	O
6	6	CD	B-NP	O
months	month	NNS	I-NP	O
ago	ago	RB	B-ADVP	O
.	.	.	O	O

Continued	Continue	VBN	B-VP	O
on	on	IN	B-PP	O
theophylline	theophylline	NN	B-NP	O
,	,	,	O	O
flovent	flovent	NN	B-NP	O
,	,	,	O	O
serevent	serevent	NN	B-NP	O
,	,	,	O	O
guifenisin	guifenisin	NN	B-NP	O
,	,	,	O	O
atrovent	atrovent	JJ	B-NP	O
inhaler	inhaler	NN	I-NP	O
prn	prn	NN	I-NP	O
.	.	.	O	O

Stable	Stable	JJ	B-NP	O
while	while	NN	I-NP	O
in	in	IN	B-PP	O
hospital	hospital	NN	B-NP	O
.	.	.	O	O

Endo	Endo	AFX	B-NP	B-protein
-	-	HYPH	I-NP	O
Pt	Pt	NN	I-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
one	one	CD	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
solumedrol	solumedrol	NN	B-NP	O
in	in	IN	B-PP	O
SCH	SCH	NN	B-NP	O
.	.	.	O	O

FS	FS	NN	B-NP	O
high	high	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	B-protein
low	low	JJ	I-NP	I-protein
200	200	CD	B-NP	I-protein
's	's	POS	B-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
;	;	:	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
begun	begin	VBN	I-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
insulin	insulin	NN	I-NP	O
SS	SS	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
require	require	VB	I-VP	O
insulin	insulin	NN	B-NP	B-protein
while	while	IN	B-SBAR	O
in	in	IN	B-PP	O
hospital	hospital	NN	B-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
Please	Please	NN	B-NP	B-protein
return	return	VB	B-VP	O
to	to	TO	B-PP	O
hospital	hospital	NN	B-NP	O
ER	ER	NN	I-NP	B-protein
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
any	any	DT	B-NP	O
chest	ch	JJS	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
increased	increase	VBD	B-VP	O
shortness	shortness	NN	B-NP	O
of	of	IN	B-PP	O
breath	breath	NN	B-NP	O
or	or	CC	I-NP	O
oxygen	oxygen	NN	I-NP	O
requirement	requirement	NN	I-NP	O
,	,	,	O	O
dizziness	dizziness	NN	B-NP	O
,	,	,	O	O
lightheadedness	lightheadedness	NN	B-NP	O
,	,	,	O	O
fainting	fainting	NN	B-NP	O
,	,	,	O	O
or	or	CC	O	O
any	any	DT	B-NP	O
other	other	JJ	I-NP	O
concerns	concern	NNS	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
palpitations	palpitation	NNS	B-NP	O
or	or	CC	O	O
a	a	DT	B-NP	O
sensation	sensation	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
racing	race	VBG	I-NP	O
heart	heart	NN	I-NP	O
,	,	,	O	O
please	please	VB	B-INTJ	O
call	call	VB	B-VP	O
your	your	PRP$	B-NP	O
primary	primary	JJ	I-NP	O
care	care	NN	I-NP	O
doctor	doctor	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-INTJ	O
go	go	VB	B-VP	O
to	to	TO	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Patricio	Patricio	NNP	I-NP	O
'	'	POS	B-NP	O
office	office	NN	I-NP	O
on	on	IN	B-PP	O
Monday	Monday	NNP	B-NP	O
for	for	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
levels	level	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Check	Check	NNP	B-NP	O
INR	INR	NN	I-NP	O
levels	level	NNS	I-NP	O
and	and	CC	O	O
adjust	adjust	VBP	B-VP	O
coumadin	coumadin	NN	B-NP	O
dose	dose	NN	I-NP	O
as	as	IN	B-PP	O
appropriate	appropriate	JJ	B-ADJP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Adjust	Adjust	NN	B-NP	O
CCB	CCB	NN	I-NP	O
and	and	CC	O	O
BBlocker	BBlocker	NN	B-NP	O
dosing	dosing	NN	I-NP	O
regimen	regimen	NN	I-NP	O
to	to	TO	B-VP	O
maintain	maintain	VB	I-VP	O
heart	heart	NN	B-NP	O
rate	rate	NN	I-NP	O
and	and	CC	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
control	control	NN	I-NP	O
as	as	IN	B-PP	O
appropriate	appropriate	JJ	B-ADJP	O
.	.	.	O	O

No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
TWILLIGEAR	TWILLIGEAR	NNP	B-NP	O
,	,	,	O	O
KOREY	KOREY	NNP	B-NP	O
N.	N.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
VQ76	VQ76	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
9/14/02	9/14/02	CD	I-NP	O
@	@	SYM	B-NP	O
04	04	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

